System and method for diagnosing lymphoma in cats
US8728751B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 12, 2011 |
| Grant date | May 20, 2014 |
| Priority date | — |
| Expiry date | May 31, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/06
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a method and a system for diagnosing lymphoma in cats. The system allows a care giver to measure the enzymatic activity of thymidine kinase in a blood sample. The invention teaches that when the enzymatic activity of thymidine kinase in the blood stream of a cat is above 15.5 Units per liter, the cat has a high probability of having lymphoma. The invention allows for initial diagnosis, follow up after treatment for lymphoma and/or monitoring for example in breeds that prone to have lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.